Please....DYOR....12 Mar 2024 07:36
...Excellent science.
Meeting A1 customers base expectations.
'Massive' and growing worldwide market.
Funding secured.
Patients protected.
Professional management team.
Directors invested alongside investors.
Tight internal finance control.
Way way undervalued, having been at the mercy, but survived short term speculators attacks.
What's not to like.
PLEASE, DONT TAKE MY WORD FOR IT ...DYOR whilst price try price attractive...DYOR.